the phase 3 tourmaline-mm2 trial
Published 3 years ago • 6 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
2:21
the phase 3 tourmaline-mm2 trial
-
6:33
the phase 3 tourmaline-mm2 trial
-
7:19
tourmaline-mm2: clinically meaningful results in multiple myeloma trial
-
2:36
what does the tourmaline-mm2 study tell us about the use of ixazomib in multiple myeloma?
-
1:22
long-term follow-up results of tourmaline-mm2: ird vs pbo-rd in multiple myeloma
-
7:11
final analysis of the phase 3 tourmaline-mm1: ixazomib lenalidomide-dex vs placebo-rd in rrmm
-
4:48
overview of the final analysis of the phase iii tourmaline-mm1 trial
-
50:26
iach journal club: the phase iii tourmaline mm4 trial
-
5:23
benefits of max 3™
-
28:21
options for treating stage iii melanoma
-
1:43
does black tourmaline protect against emf's? | emf protector
-
4:19
tourmaline-mm3 and 4: ixazomib as maintenance therapy in myeloma patients
-
7:45
extrapolating from clinical trials: daratumumab in mm
-
9:51
lenalidomide, bortezomib, and dexamethasone asct to progress for ndmm: phase 3 determination trial
-
1:55
dr. mateos on ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
-
2:54
tourmaline-mm4: oral ixazomib maintenance for myeloma
-
1:08
long term follow-up results from the phase iii maia trial in myeloma
-
17:10
the initial results from the phase 3 boston study for multiple myeloma
-
1:04
dr. kumar on ixazomib combo for multiple myeloma treatment
-
2:34
how should smoldering multiple myeloma be monitored?
-
1:12
dr. kumar on tourmaline-mm1 study for multiple myeloma
-
12:25
3 step algorithm for acral melanocytic lesions - dr. toshiaki saida